Cliff Asness's RAPP Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 25,510 shares of Rapport Therapeutics, Inc. (RAPP) worth $798,208, representing 0.00% of the portfolio. First purchased in 2025-Q2, this short-term holding has been held for 4 quarters.
Based on 13F filings, Cliff Asness has maintained this position in RAPP for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 4,632 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Rapport Therapeutics (RAPP) Holding Value Over Time
Track share changes against reported price movement
Quarterly Rapport Therapeutics (RAPP) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +4,632 | Add 22.19% | 25,510 | $31.29 |
| Q4 2025 | +256 | Add 1.24% | 20,878 | $30.34 |
| Q3 2025 | +3,650 | Add 21.51% | 20,622 | $29.70 |
| Q2 2025 | +16,972 | New Buy | 16,972 | $11.37 |
Cliff Asness's Rapport Therapeutics Investment FAQs
Cliff Asness first purchased Rapport Therapeutics, Inc. (RAPP) in Q2 2025, acquiring 16,972 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Rapport Therapeutics, Inc. (RAPP) for 4 quarters since Q2 2025.
Cliff Asness's largest addition to Rapport Therapeutics, Inc. (RAPP) was in Q2 2025, adding 16,972 shares worth $192,971.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 25,510 shares of Rapport Therapeutics, Inc. (RAPP), valued at approximately $798,208.
As of the Q1 2026 filing, Rapport Therapeutics, Inc. (RAPP) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Rapport Therapeutics, Inc. (RAPP) was 25,510 shares, as reported at the end of Q1 2026.